论文部分内容阅读
近年来急性白血病由于联合化疗及免疫治疗,使疗效有所提高,生存期在五年以上者逐年增加。但对慢性粒细胞性白血病的治疗则进展不大。其平均生存期也很难证明有显著延长。在慢粒病人中除因感染、出血、衰竭或其他合并症死亡者外,多发生急性变(有报告发生率高达70～80％),而且一旦发生急性变后即难于治疗。现结合文献将诊断为慢粒急变的13例进行分析于下:
In recent years, acute leukemia combined with chemotherapy and immunotherapy, so that efficacy has improved, the survival of more than five years increased year by year. However, the treatment of chronic myeloid leukemia is not progress. The average survival is also difficult to prove a significant extension. In patients with chronic myeloma died of infection, bleeding, failure or other complications, the more acute change occurs (the reported rate of up to 70 to 80%), and in the event of acute change that is difficult to treat. Now combined with the literature will be diagnosed as chronic myogenic change in 13 cases analyzed as follows: